Related Experiment Video
Updated: Oct 3, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Abstract:
Between 1980/86 there were 58 cases of uterine cancer reviewed at the Mater Misericordiae Hospital, of which 49 (84.5%) had endometrial adenocarcinoma. The median survival in Stage I disease was 30 months and where applicable the overall five-year survival rate was 43.75%. These survival rates are less than those reported from most other centres. This reduced survival rate was not related to presentation with more advanced disease. However, patients were of an older age and had a greater number of poorly differentiated tumours than in other reported series. Comparative results with other centres in Ireland would be assisted by the establishment of a National Tumour Registry.

